Zhongxing BioTech released its performance for the first three quarters, with a net profit attributable to the parent company of 204 million yuan, a year-on-year increase of 130.51%Zhitong·Oct 27, 2025 at 11:25 AM002772-1.31%
Zhongxing BioTech provides guarantees for its subsidiaries, with a cumulative guarantee balance exceeding 1.1 billion yuanZhitong·Oct 16, 2025 at 03:19 AM002772-1.31%
Zhongxing BioTech plans to launch a stock option incentive plan for 14.375 million sharesZhitong·Sep 25, 2025 at 07:45 AM002772-1.31%
Zhongxing BioTech: Recently, there have been no significant changes in the company's operating conditions or the internal and external operating environmentZhitong·Sep 14, 2025 at 02:48 AM002772-1.31%
Zhongxing BioTech: Net profit in the first half of the year is expected to increase by 86.57%-137.46% year-on-yearZhitong·Jul 14, 2025 at 05:45 AM002772-1.31%
Zhongxing BioTech and others established a technology company, including the business of biological organic fertilizersZhitong·Jul 10, 2025 at 09:01 PM002772-1.31%
Zhongxing BioTech plans to invest approximately 700 million yuan to build a southwestern headquarters base for the food and medicinal mushroom industry to improve its business layoutZhitong·Jun 6, 2025 at 04:42 AM002772-1.31%
Agricultural stocks fluctuate and rise, Cynda hits the daily limit in the afternoon36Kr·Apr 21, 2025 at 12:07 AM002215-1.76%000833+0.34%
Zhongxing BioTech released its first-quarter performance, with a net profit attributable to the parent company of 48.2002 million yuan, a year-on-year increase of 38.72%Zhitong·Apr 18, 2025 at 05:57 AM002772-1.31%
Zhongxing BioTech released its 2024 annual performance, with a net profit attributable to the parent company of 128 million yuan, a year-on-year decrease of 19.77%Zhitong·Mar 21, 2025 at 06:06 AM002772-1.31%
Zhongxing BioTech plans to invest CNY 123 million to implement the industrialized bionic cultivation renovation project for Cordyceps sinensisZhitong·Feb 18, 2025 at 05:56 AM002772-1.31%
Zhongxing BioTech has completed its repurchase, with a total expenditure of 143 million yuan to repurchase approximately 4.7% of its sharesZhitong·Feb 10, 2025 at 04:15 AM002772-1.31%
Zhongxing BioTech has repurchased a total of 4.5868% of its shares, costing approximately 140 million yuanZhitong·Feb 6, 2025 at 03:18 AM002772-1.31%
Zhongxing BioTech has repurchased a total of 16.0832 million shares at a cost of 125 million yuanZhitong·Jan 2, 2025 at 05:20 AM002772-1.31%
Zhongxing BioTech has repurchased 4.01% of its shares at a cost of 123 million yuanZhitong·Dec 23, 2024 at 04:25 AM002772-1.31%
